SLNSW-Pamiparib in combination with tislelizumab in pat...-TN_cdi_proquest_journals_2283212625

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Full title: Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Author/creator: Friedlander, Michael, Prof, Meniawy, Tarek, PhD, Markman, Ben, MBBS, Mileshkin, Linda, MD, Harnett, Paul, Prof, Millward, Michael, MBBS, Lundy, Joanne, MBBS, Freimund, Alison, MBBS, Norris, Christie, RN, Mu, Song, PhD, Wu, John, PhD, Paton, Virginia, PharmD, Gao, Bo, PhD.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2283212625

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2283212625

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

    Record identifier

    TN_cdi_proquest_journals_2283212625

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2283212625

    Share

    Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2283212625

    Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

    Full title

    Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

    Author / Creator

    Friedlander, Michael, Prof ; Meniawy, Tarek, PhD ; Markman, Ben, MBBS ; Mileshkin, Linda, MD ; Harnett, Paul, Prof ; Millward, Michael, MBBS ; Lundy, Joanne, MBBS ; Freimund, Alison, MBBS ; Norris, Christie, RN ; Mu, Song, PhD ; Wu, John, PhD ; Paton, Virginia, PharmD ; Gao, Bo, PhD

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2019, Vol.20 (9), p.1306-1315

    Record Identifier

    TN_cdi_proquest_journals_2283212625

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Analysis Apoptosis Cancer therapies Corticosteroids Deoxyribonucleic acid Diarrhea Disease control DNA DNA repair Hematology, Oncology, and Palliative Medicine Hepatitis Immune checkpoint Immunoglobulins Immunotherapy Intravenous administration Life span Lung cancer Monoclonal antibodies Monosaccharides Mutation Nausea Oncology Ovarian cancer Pain Patients PD-1 protein Poly(ADP-ribose) polymerase Ribose Safety Solid tumors Studies Sugars Toxicity Tumors Vomiting

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2283212625

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2283212625

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections